Cellectis CLLS
NASDAQ CLLS
$0.91 -0.08 (-8.02%)
As of: Oct 21, 2026 · 2:33 PM EDT

Cellectis (CLLS) Total Current Liabilities (2013 - 2026)

Updated

Cellectis (CLLS) recorded Total Current Liabilities of $7.5 million in Q2 2026, down 95.5% from $167.43 million a year earlier and down 15.8% from the prior quarter.

Analysis

Cellectis (CLLS) Total Current Liabilities (2013 - 2026) Analysis & Trends

At the end of FY2025, Cellectis reported Total Current Liabilities of $10.46 million, down 35.2% from FY2024.

  • Annual Total Current Liabilities has a five-year compound annual growth rate of -27.4% (FY2020 to FY2025).
  • Across earlier years, Total Current Liabilities came in at $16.13 million in FY2024 (+205.0%), $5.29 million in FY2023 (+4.0%), $5.09 million in FY2022 (+116.1%) and $2.35 million in FY2021 (-95.5%).
  • The Q2 2026 figure is the lowest quarterly Total Current Liabilities since Q3 2024.
  • On a year-over-year basis, Total Current Liabilities has declined for three consecutive quarters, with growth averaging 51.2% over the last eight quarters.
  • Peak year-over-year performance for Total Current Liabilities in the last five years was growth of 323.5% in Q3 2023, against a decline of 95.5% in Q2 2026 at the low end.
  • Per Business Quant, the preceding three quarters came in at $8.9 million (Q1 2026), $10.46 million (Q4 2025) and $18.24 million (Q3 2025).
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Total Current Liabilities (Qtr)
1 Eli Lilly 1,135.99 Bn 1,104.58 Bn 19.71 Bn 47.74 Bn
2 Johnson & Johnson 616.90 Bn 535.42 Bn 17.26 Bn 54.90 Bn
3 AbbVie 501.56 Bn 474.68 Bn 12.70 Bn 41.64 Bn
4 Merck 367.41 Bn 321.79 Bn 12.21 Bn 27.73 Bn
5 Novartis Ag 297.75 Bn 261.74 Bn 11.24 Bn 31.75 Bn
6 Astrazeneca 261.45 Bn 235.13 Bn 12.86 Bn 31.55 Bn
7 Amgen 236.48 Bn 191.88 Bn 7.24 Bn 25.50 Bn
8 Gilead Sciences 190.56 Bn 164.76 Bn 6.22 Bn 11.02 Bn
9 Pfizer 169.46 Bn 116.11 Bn 10.94 Bn 32.65 Bn
10 Cellectis 95.27 Mn -658.13 Mn - 134.96 Mn
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 134.96 Mn
Mar 31, 2026 134.50 Mn
Dec 31, 2025 145.75 Mn
Sep 30, 2025 148.58 Mn
Jun 30, 2025 167.43 Mn
Mar 31, 2025 162.57 Mn
Dec 31, 2024 166.27 Mn
Sep 30, 2024 165.65 Mn
Jun 30, 2024 159.63 Mn
Mar 31, 2024 158.45 Mn
Dec 31, 2023 155.14 Mn
Sep 30, 2023 43.95 Mn
Jun 30, 2023 42.05 Mn
Mar 31, 2023 43.14 Mn
Dec 31, 2022 48.13 Mn
Sep 30, 2022 53.03 Mn
Jun 30, 2022 55.28 Mn
Mar 31, 2022 52.34 Mn
Dec 31, 2021 49.35 Mn
Sep 30, 2021 49.60 Mn
API Access

Cellectis Total Current Liabilities API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=total-current-liabilities&ticker=CLLS&period=max&api_key=YOUR_API_KEY